论文部分内容阅读
目的:探讨干扰素联合炎琥宁对于治疗小儿足口病的临床效果.方法:将本院而从2016年1月-2017年12月期间收治的46例患儿随机分为实验组和对照组两组,每组23人,对两组患儿给予对症治疗的不同方案,对照组患儿采用利巴韦林治疗,而实验组患儿则采用干扰素联合炎琥宁进行治疗,5d一个疗程,然后观察两组患儿治疗的临床效果以及用药后退热时间、手足口疱疹和住院时间.结果:实验组患儿在用药后,其平均退热时间、手足口疱疹和住院时间均明显短于对照组.差异有统计学意义(P<0.05).实验组的临床效果中的显著率和总有效率均明显高过对照组,差异有统计学意义(P<0.05).结论:通过对比结果可知,采用干扰素联合炎琥宁治疗小儿手足口病的临床效果明显好于采用利巴韦林,具有更高的应用价值.,objective:to explore the clinical effect of interferon combined with suxunning on the treatment of pediatric foot stomatitis.Methods:will in our hospital from January 2016-December 2017 of 46 cases were randomly divided into experimental group and control group in the two groups,each group of 23 people,to give symptomatic treatment of different solutions to the two groups of children,children with the control group using ribavirin treatment,while the experimental group with the interferon joint inflammation Hu better treatment,5 d a course of treatment,and then observe the clinical effect of two groups of children with treatment and medication after the defervescence time,hand,foot and mouth sores and length of hospital stay.Results:the average fever time,herpes and hospitalization in the experimental group were significantly shorter than those in the control group.The difference was statistically significant(P<0.05).The clinical effect of the experimental group was significantly higher than that in the control group,and the difference was statistically significant(P<0.05).Conclusion:the results show that the clinical effect of combined with interferon combined with the treatment of HFMD is better than that of libavirin,which is of higher application value.